HDAC1 and liver cancer: Given the elevation of the HDAC1-Sp5 pathway seen in patients with pediatric liver cancers (Figure 2), we have utilized a recently established protocol for generating cell lines with metastatic activities [13] and have established new cell lines from these patients.